Patrick J. Earley
Corporate Officer/Principal presso CTI Clinical Trial & Consulting Services, Inc.
Profilo
Patrick J.
Earley is currently the Chief International Business Officer at CTI Clinical Trial & Consulting Services, Inc. He holds a Master's in Business Administration from Xavier University and an undergraduate degree from West Liberty State College (West Virginia).
Posizioni attive di Patrick J. Earley
Società | Posizione | Inizio |
---|---|---|
CTI Clinical Trial & Consulting Services, Inc.
CTI Clinical Trial & Consulting Services, Inc. Miscellaneous Commercial ServicesCommercial Services CTI Clinical Trial & Consulting Services, Inc. engages in the provision o clinical trial and consulting services. It offers multi-specialty clinical research site that conducts phase I-IV trials. The firm focuses in therapeutic approach for pharmaceutical, biotechnology, and medical device firms with clinical and disease area expertise in rare diseases, regenerative medicine and gene therapy, immunology, transplantation, nephrology, hematology and oncology, neurology, infectious diseases, hematology, cardiopulmonary, and pediatric populations. The company was founded by Timothy J. Schroeder and Lynn Fallon in 1999 and is headquartered in Covington, KY. | Corporate Officer/Principal | 13/05/2014 |
Formazione di Patrick J. Earley
Xavier University | Masters Business Admin |
West Liberty State College (West Virginia) | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 1 |
---|---|
CTI Clinical Trial & Consulting Services, Inc.
CTI Clinical Trial & Consulting Services, Inc. Miscellaneous Commercial ServicesCommercial Services CTI Clinical Trial & Consulting Services, Inc. engages in the provision o clinical trial and consulting services. It offers multi-specialty clinical research site that conducts phase I-IV trials. The firm focuses in therapeutic approach for pharmaceutical, biotechnology, and medical device firms with clinical and disease area expertise in rare diseases, regenerative medicine and gene therapy, immunology, transplantation, nephrology, hematology and oncology, neurology, infectious diseases, hematology, cardiopulmonary, and pediatric populations. The company was founded by Timothy J. Schroeder and Lynn Fallon in 1999 and is headquartered in Covington, KY. | Commercial Services |
- Borsa valori
- Insiders
- Patrick J. Earley